Behcet's Disease: Systemic and Ocular Manifestations
Overview
Biotechnology
General Medicine
Affiliations
Aim: The aim of this study was to evaluate if patients with Behcet's disease who have ocular involvement have a more severe form of this disease as compared to patients with Behcet's disease alone.
Methods: A total of 99 patients were included in the study. 76 patients were used as part of the examined group, and 23 patients formed a control group.
Results: The following are the results of examined and control groups, respectively: recurrent oral aphthous ulcers 89.5%, 95.7%; genital ulcers 61.8%, 97.0%; articular involvement 72.4%, 65.2%; vasculitis 81.6%, 60.9%; positive pathergy test 25.0%, 47.8%. Higher frequency of genital ulcerations was noted in control group (P = 0.001). More than two major criteria were met in 100% of the cases. HLA B51 was present in 78.9% of the cases in the examined group and 43.5% of the cases in control group; thus there is significant difference between them (P = 0.001). Visual acuity >0.5 occurred in 76% (examined group). Most frequent ocular manifestations in the examined group were retinal periphlebitis 81.6%, periphlebitis and periarteritis 65%, and serofibrinous uveitis 63.2%. Macular edema as a complication was present in 63.2%. The majority of patients (55.3%) were treated with combined therapy consisting of cyclosporine A and systemic corticosteroids. In 38.2% of patients, laser photocoagulation was used on retinal periphery.
Sahin A, Batu Oto B, Uzun Adatepe N, Ucar D Int Ophthalmol. 2024; 44(1):76.
PMID: 38351422 DOI: 10.1007/s10792-024-02927-y.
Degirmenci M, Yalcindag F Graefes Arch Clin Exp Ophthalmol. 2023; 261(11):3275-3281.
PMID: 37773289 DOI: 10.1007/s00417-023-06249-0.
Al Kharousi N, Alnaabi K, Almahrouqi O, Mal W Oman J Ophthalmol. 2023; 15(3):269-273.
PMID: 36760938 PMC: 9905896. DOI: 10.4103/ojo.ojo_68_22.
MicroRNAs in the regulation of Th17/Treg homeostasis and their potential role in uveitis.
Tang F, Zhou Z, Huang K, Deng W, Lin J, Chen R Front Genet. 2022; 13:848985.
PMID: 36186459 PMC: 9515448. DOI: 10.3389/fgene.2022.848985.
Epidemiology of Ocular Manifestations in Autoimmune Disease.
Glover K, Mishra D, Raghu Raj Singh T Front Immunol. 2021; 12:744396.
PMID: 34795665 PMC: 8593335. DOI: 10.3389/fimmu.2021.744396.